Chargement en cours...
The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype
The genomics-based molecular classifications aim at identifying more homogeneous classes than immunohistochemistry, associated with a more uniform clinical outcome. We conducted an in silico analysis on a meta-dataset including gene expression data from 5342 clinically defined ER+/HER2− breast cance...
Enregistré dans:
| Publié dans: | NPJ Breast Cancer |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group UK
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7060267/ https://ncbi.nlm.nih.gov/pubmed/32195331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-020-0151-5 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|